Nicko displays the device, a Philips DreamStation, to the camera, noting that it has “now been recalled.” He claims this is because the sound-abating foam inside breaks down, “and then it travels into ...

A group of over hundred institutional investors are claiming over 800 million euros worth of damages from Philips. The ...

The global respiratory diagnostics market, valued at US$ 5.85 billion in 2023, is forecasted to grow at a robust CAGR of 6.5%, reaching US$ ...

Advancing Light Therapy Research to Enhance Quality of Life for Parkinson's Patients This trial is important becau ...

Koninklijke Philips NV (ETR:PHI1 ... forecast also includes an expected margin improvement and a recovery of the Respironics business. These factors are projected to contribute to a compound ...

Dr. Hauser's dedication to patient-centered care and his expertise in advancing scientific discovery make him uniquely qualified ...

I’m sure many other biotechs are active in the field. Due to the ongoing problems at Philips Respironics, RMD continues to benefit from the absence of a key competitor in the US OSA/respiratory ...

A coalition of influential Pittsburgh-area stakeholders wants to make the region a competitive leader in artificial ...

The powerful Inspiration Elite is the newest and lightest compressor nebulizer system in the Respironics family is here. It's durable, easy to use and easy to maintain. But best of all ...

The global respiratory diagnostics market, valued at US$ 5.85 billion in 2023, is forecasted to grow at a robust CAGR of 6.5%, reaching US$ 6.17 billion in 2024 and an impressive US$ 9.02 billion by ...

Starting with positive news, the CEO communicated a return to cash dividends, as Philips’ balance sheet is in good shape (even considering the settling for $1.1 billion). Additionally ...